Levitsky HI - Search Results

1

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P. Fearon ER, et al. Among authors: levitsky hi. Cell. 1990 Feb 9;60(3):397-403. doi: 10.1016/0092-8674(90)90591-2. Cell. 1990. PMID: 2137372 Free article.

2

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M, Pardoll DM. Golumbek PT, et al. Among authors: levitsky hi. Science. 1991 Nov 1;254(5032):713-6. doi: 10.1126/science.1948050. Science. 1991. PMID: 1948050

3

Molecular engineering of the antitumor immune response.

Pardoll DM, Golumbek P, Levitsky H, Jaffee L. Pardoll DM, et al. Bone Marrow Transplant. 1992;9 Suppl 1:182-6. Bone Marrow Transplant. 1992. PMID: 1387016 Review. No abstract available.

4

The antitumor immune response as a problem of self-nonself discrimination: implications for immunotherapy.

Golumbek P, Levitsky H, Jaffee L, Pardoll DM. Golumbek P, et al. Immunol Res. 1993;12(2):183-92. doi: 10.1007/BF02918303. Immunol Res. 1993. PMID: 8254226 Review.

5

The fate of CD4-8- T cell receptor-alpha beta+ thymocytes.

Levitsky HI, Golumbek PT, Pardoll DM. Levitsky HI, et al. J Immunol. 1991 Feb 15;146(4):1113-7. J Immunol. 1991. PMID: 1825103

6

A reassessment of the role of B7-1 expression in tumor rejection.

Wu TC, Huang AY, Jaffee EM, Levitsky HI, Pardoll DM. Wu TC, et al. Among authors: levitsky hi. J Exp Med. 1995 Nov 1;182(5):1415-21. doi: 10.1084/jem.182.5.1415. J Exp Med. 1995. PMID: 7595212 Free PMC article.

7

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

Levitsky HI, Lazenby A, Hayashi RJ, Pardoll DM. Levitsky HI, et al. J Exp Med. 1994 Apr 1;179(4):1215-24. doi: 10.1084/jem.179.4.1215. J Exp Med. 1994. PMID: 7908321 Free PMC article.

8

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.

Golumbek PT, Azhari R, Jaffee EM, Levitsky HI, Lazenby A, Leong K, Pardoll DM. Golumbek PT, et al. Among authors: levitsky hi. Cancer Res. 1993 Dec 15;53(24):5841-4. Cancer Res. 1993. PMID: 8261390

9

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Wu TC, Guarnieri FG, Staveley-O'Carroll KF, Viscidi RP, Levitsky HI, Hedrick L, Cho KR, August JT, Pardoll DM. Wu TC, et al. Among authors: levitsky hi. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11671-5. doi: 10.1073/pnas.92.25.11671. Proc Natl Acad Sci U S A. 1995. PMID: 8524826 Free PMC article.

10

In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

Huang AY, Bruce AT, Pardoll DM, Levitsky HI. Huang AY, et al. Among authors: levitsky hi. Immunity. 1996 Apr;4(4):349-55. doi: 10.1016/s1074-7613(00)80248-4. Immunity. 1996. PMID: 8612129 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters